← All Mutual Funds

BlackRock Health Sciences Term Trust

CIK: 0001785971 BMEZ Equity
Report date: 2026-05-28
AUM $1.0B
Expense Ratio —
Category Equity
State MD
Fiscal Year End —
Inception Date —
Manager —
Latest Filing 2026-05-28

Holdings

From latest SEC N-PORT filing · US-listed stocks only

101 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-07-07 002824100 Equity (Common)
0.70%
 $7.07 68,889
2 ABBV AbbVie Inc Since 2026-07-07 00287Y109 Equity (Common)
1.28%
 $13.00 59,784
3 A Agilent Technologies Inc Since 2026-07-07 00846U101 Equity (Common)
1.27%
 $12.83 112,566
4 AGIO Agios Pharmaceuticals Inc Since 2026-07-07 00847X104 Equity (Common)
0.33%
 $3.37 99,595
5 AKTS Aktis Oncology Inc Since 2026-07-07 01021M104 Equity (Common)
0.10%
 $1.05 58,563
6 ALLO Allogene Therapeutics Inc Since 2026-07-07 019770106 Equity (Common)
0.08%
 $0.85 348,877
7 ALMS Alumis Inc Since 2026-07-07 022307102 Equity (Common)
0.22%
 $2.24 101,619
8 AMGN Amgen Inc Since 2026-07-07 031162100 Equity (Common)
1.57%
 $15.93 45,282
9 APGE Apogee Therapeutics Inc Since 2026-07-07 03770N101 Equity (Common)
0.34%
 $3.44 40,862
10 ACLX Arcellx Inc Since 2026-07-07 03940C100 Equity (Common)
0.35%
 $3.58 31,135
11 RCUS Arcus Biosciences Inc Since 2026-07-07 03969F109 Equity (Common)
0.35%
 $3.58 165,805
12 ARVN Arvinas Inc Since 2026-07-07 04335A105 Equity (Common)
0.10%
 $1.00 94,854
13 ASND Ascendis Pharma A/S Since 2026-07-07 04351P101 Equity (Common)
0.09%
 $0.95 4,166
14 AVTX Avalo Therapeutics Inc Since 2026-07-07 05338F306 Equity (Common)
0.05%
 $0.46 30,621
15 AXSM Axsome Therapeutics Inc Since 2026-07-07 05464T104 Equity (Common)
0.48%
 $4.86 28,760
16 BCAX Bicara Therapeutics Inc Since 2026-07-07 055477103 Equity (Common)
0.10%
 $1.05 52,958
17 BEAM Beam Therapeutics Inc Since 2026-07-07 07373V105 Equity (Common)
0.18%
 $1.83 76,864
18 BIO.B Bio-Rad Laboratories Inc Since 2026-07-07 090572207 Equity (Common)
0.48%
 $4.91 17,608
19 BMRN BioMarin Pharmaceutical Inc Since 2026-07-07 09061G101 Equity (Common)
0.18%
 $1.79 31,662
20 BIIB Biogen Inc Since 2026-07-07 09062X103 Equity (Common)
2.49%
 $25.20 137,487
21 BBOT BridgeBio Oncology Therapeutics Inc Since 2026-07-07 107924102 Equity (Common)
0.23%
 $2.36 263,669
22 BBIO Bridgebio Pharma Inc Since 2026-07-07 10806X102 Equity (Common)
1.00%
 $10.16 136,783
23 DRUG Bright Minds Biosciences Inc Since 2026-07-07 10919W405 Equity (Common)
0.23%
 $2.33 31,933
24 CRL Charles River Laboratories International Inc Since 2026-07-07 159864107 Equity (Common)
1.04%
 $10.50 60,883
25 COGT Cogent Biosciences Inc Since 2026-07-07 19240Q201 Equity (Common)
0.53%
 $5.33 138,610
26 CRVS Corvus Pharmaceuticals Inc Since 2026-07-07 221015100 Equity (Common)
0.04%
 $0.36 24,771
27 CTMX CytomX Therapeutics Inc Since 2026-07-07 23284F105 Equity (Common)
0.10%
 $1.01 215,748
28 DNLI Denali Therapeutics Inc Since 2026-07-07 24823R105 Equity (Common)
0.15%
 $1.50 78,053
29 DXCM Dexcom Inc Since 2026-07-07 252131107 Equity (Common)
1.07%
 $10.88 173,259
30 DNTH Dianthus Therapeutics Inc Since 2026-07-07 252828108 Equity (Common)
0.52%
 $5.23 62,279
31 DYN Dyne Therapeutics Inc Since 2026-07-07 26818M108 Equity (Common)
0.14%
 $1.47 80,931
32 EWTX Edgewise Therapeutics Inc Since 2026-07-07 28036F105 Equity (Common)
0.28%
 $2.81 89,151
33 EIKN Eikon Therapeutics Inc Since 2026-07-07 282564103 Equity (Common)
0.13%
 $1.29 121,628
34 ENTA Enanta Pharmaceuticals Inc Since 2026-07-07 29251M106 Equity (Common)
0.09%
 $0.88 69,729
35 ELVN Enliven Therapeutics Inc Since 2026-07-07 29337E102 Equity (Common)
0.21%
 $2.15 54,885
36 ERAS Erasca Inc Since 2026-07-07 29479A108 Equity (Common)
0.25%
 $2.58 159,240
37 EXEL Exelixis Inc Since 2026-07-07 30161Q104 Equity (Common)
0.89%
 $9.01 210,176
38 EYPT EyePoint Inc Since 2026-07-07 30233G209 Equity (Common)
0.10%
 $0.97 75,092
39 FDMT 4D Molecular Therapeutics Inc Since 2026-07-07 35104E100 Equity (Common)
0.04%
 $0.39 41,862
40 GILD Gilead Sciences Inc Since 2026-07-07 375558103 Equity (Common)
2.96%
 $29.93 214,745
41 GOSS Gossamer Bio Inc Since 2026-07-07 38341P102 Equity (Common)
0.00%
 $0.02 60,195
42 GH Guardant Health Inc Since 2026-07-07 40131M109 Equity (Common)
2.02%
 $20.45 221,348
43 HALO Halozyme Therapeutics Inc Since 2026-07-07 40637H109 Equity (Common)
0.40%
 $4.09 63,226
44 HOLX Hologic Inc Since 2026-07-07 436440101 Equity (Common)
1.02%
 $10.37 137,197
45 ILMN Illumina Inc Since 2026-07-07 452327109 Equity (Common)
1.42%
 $14.34 116,338
46 IMNM Immunome Inc Since 2026-07-07 45257U108 Equity (Common)
0.15%
 $1.56 71,450
47 NTLA Intellia Therapeutics Inc Since 2026-07-07 45826J105 Equity (Common)
0.17%
 $1.69 131,520
48 ISRG Intuitive Surgical Inc Since 2026-07-07 46120E602 Equity (Common)
1.07%
 $10.87 23,573
49 IONS Ionis Pharmaceuticals Inc Since 2026-07-07 462222100 Equity (Common)
0.52%
 $5.27 70,173
50 IQV IQVIA Holdings Inc Since 2026-07-07 46266C105 Equity (Common)
0.79%
 $7.97 46,747
51 JNJ Johnson & Johnson Since 2026-07-07 478160104 Equity (Common)
3.52%
 $35.60 145,639
52 KALV KalVista Pharmaceuticals Inc Since 2026-07-07 483497103 Equity (Common)
0.14%
 $1.42 70,390
53 KOD Kodiak Sciences Inc Since 2026-07-07 50015M109 Equity (Common)
0.12%
 $1.23 32,224
54 KYMR Kymera Therapeutics Inc Since 2026-07-07 501575104 Equity (Common)
0.11%
 $1.16 13,937
55 LBRX LB Pharmaceuticals Inc Since 2026-07-07 50180M108 Equity (Common)
0.51%
 $5.13 207,987
56 LNTH Lantheus Holdings Inc Since 2026-07-07 516544103 Equity (Common)
0.36%
 $3.66 48,294
57 MBX MBX Biosciences Inc Since 2026-07-07 55287L101 Equity (Common)
0.38%
 $3.84 128,549
58 MAZE Maze Therapeutics Inc Since 2026-07-07 578784100 Equity (Common)
0.13%
 $1.33 44,725
59 MDLN Medline Inc Since 2026-07-07 58507V107 Equity (Common)
0.62%
 $6.31 141,863
60 MRK Merck & Co Inc Since 2026-07-07 58933Y105 Equity (Common)
3.12%
 $31.56 262,388
61 MRNA Moderna Inc Since 2026-07-07 60770K107 Equity (Common)
2.76%
 $27.93 549,814
62 GLUE Monte Rosa Therapeutics Inc Since 2026-07-07 61225M102 Equity (Common)
0.11%
 $1.16 70,406
63 MLTX MoonLake Immunotherapeutics Since 2026-07-07 61559X104 Equity (Common)
0.05%
 $0.52 28,105
64 NTRA Natera Inc Since 2026-07-07 632307104 Equity (Common)
1.64%
 $16.57 82,862
65 NBIX Neurocrine Biosciences Inc Since 2026-07-07 64125C109 Equity (Common)
1.04%
 $10.50 79,676
66 NGNE Neurogene Inc Since 2026-07-07 64135M105 Equity (Common)
0.07%
 $0.73 36,199
67 NUVL Nuvalent Inc Since 2026-07-07 670703107 Equity (Common)
0.53%
 $5.33 52,024
68 NUVB Nuvation Bio Inc Since 2026-07-07 67080N101 Equity (Common)
0.12%
 $1.22 283,833
69 OCUL Ocular Therapeutix Inc Since 2026-07-07 67576A100 Equity (Common)
0.06%
 $0.65 76,913
70 ORIC ORIC Pharmaceuticals Inc Since 2026-07-07 68622P109 Equity (Common)
0.12%
 $1.25 99,005
71 ORKA Oruka Therapeutics Inc Since 2026-07-07 687604108 Equity (Common)
0.23%
 $2.38 48,426
72 PTCT PTC Therapeutics Inc Since 2026-07-07 69366J200 Equity (Common)
0.23%
 $2.34 34,361
73 PVLA Palvella Therapeutics Inc Since 2026-07-07 697947109 Equity (Common)
0.26%
 $2.65 21,246
74 NVS Novartis AG Since 2026-07-07 — Equity (Common)
1.58%
 $16.02 104,397
75 PFE Pfizer Inc Since 2026-07-07 717081103 Equity (Common)
1.49%
 $15.13 538,786
76 PTGX Protagonist Therapeutics Inc Since 2026-07-07 74366E102 Equity (Common)
0.72%
 $7.26 68,855
77 RDNT RadNet Inc Since 2026-07-07 750491102 Equity (Common)
0.26%
 $2.62 46,906
78 RGNX REGENXBIO Inc Since 2026-07-07 75901B107 Equity (Common)
0.07%
 $0.68 81,282
79 RVMD Revolution Medicines Inc Since 2026-07-07 76155X100 Equity (Common)
0.45%
 $4.57 46,968
80 RYTM Rhythm Pharmaceuticals Inc Since 2026-07-07 76243J105 Equity (Common)
0.96%
 $9.69 111,452
81 SGMT Sagimet Biosciences Inc Since 2026-07-07 786700104 Equity (Common)
0.11%
 $1.15 220,227
82 STOK Stoke Therapeutics Inc Since 2026-07-07 86150R107 Equity (Common)
0.43%
 $4.32 132,656
83 SMMT Summit Therapeutics Inc Since 2026-07-07 86627T108 Equity (Common)
0.22%
 $2.20 116,250
84 SNDX Syndax Pharmaceuticals Inc Since 2026-07-07 87164F105 Equity (Common)
0.06%
 $0.57 24,320
85 TEM Tempus AI Inc Since 2026-07-07 88023B103 Equity (Common)
0.35%
 $3.52 77,823
86 TERN Terns Pharmaceuticals Inc Since 2026-07-07 880881107 Equity (Common)
0.81%
 $8.19 155,371
87 TMO Thermo Fisher Scientific Inc Since 2026-07-07 883556102 Equity (Common)
0.44%
 $4.45 9,062
88 TCRX TScan Therapeutics Inc Since 2026-07-07 89854M101 Equity (Common)
0.04%
 $0.41 407,010
89 UPB Upstream Bio Inc Since 2026-07-07 91678A107 Equity (Common)
0.05%
 $0.51 56,530
90 VKTX Viking Therapeutics Inc Since 2026-07-07 92686J106 Equity (Common)
0.18%
 $1.83 56,322
91 VRDN Viridian Therapeutics Inc Since 2026-07-07 92790C104 Equity (Common)
0.33%
 $3.39 173,120
92 VOR Vor BioPharma Inc Since 2026-07-07 929033207 Equity (Common)
0.08%
 $0.78 43,710
93 VYGR Voyager Therapeutics Inc Since 2026-07-07 92915B106 Equity (Common)
0.05%
 $0.55 141,787
94 KLRA KAILERA THERAPEUTICS INC Since 2026-07-07 — Equity (Common)
0.35%
 $3.50 250,286
95 NYXH Nyxoah SA Since 2026-07-07 — Equity (Common)
0.03%
 $0.33 112,019
96 AZN AstraZeneca PLC Since 2026-07-07 — Equity (Common)
1.13%
 $11.41 57,869
97 BHVN Biohaven Ltd Since 2026-07-07 — Equity (Common)
0.04%
 $0.40 46,808
98 KNSA Kiniksa Pharmaceuticals International Plc Since 2026-07-07 — Equity (Common)
0.30%
 $3.08 64,037
99 MDT Medtronic PLC Since 2026-07-07 — Equity (Common)
0.99%
 $9.99 115,270
100 ROIV Roivant Sciences Ltd Since 2026-07-07 — Equity (Common)
0.66%
 $6.66 240,456
101 WVE WaVe Life Sciences Ltd Since 2026-07-07 — Equity (Common)
0.07%
 $0.70 96,283
Frequently Asked Questions — BlackRock Health Sciences Term Trust
What type of mutual fund is BlackRock Health Sciences Term Trust?
BlackRock Health Sciences Term Trust is a SEC-registered Equity fund, with $1.0B in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, BlackRock Health Sciences Term Trust holds 101 portfolio positions, all detailed in the holdings table on this page.
What are BlackRock Health Sciences Term Trust's assets under management (AUM)?
BlackRock Health Sciences Term Trust has $1.0B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are BlackRock Health Sciences Term Trust's top holdings?
According to BlackRock Health Sciences Term Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie Inc, Agilent Technologies Inc , among others. The complete list of all 101 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is BlackRock Health Sciences Term Trust's expense ratio?
Expense ratio data for BlackRock Health Sciences Term Trust is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find BlackRock Health Sciences Term Trust's SEC filings?
BlackRock Health Sciences Term Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001785971. You can access all of BlackRock Health Sciences Term Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001785971). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is BlackRock Health Sciences Term Trust's holdings data on StockSifting?
Holdings data for BlackRock Health Sciences Term Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.